Stock SNOA SONOMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.2047 USD -0.15% Intraday chart for Sonoma Pharmaceuticals, Inc. +3.75% +13.47%
May. 09 Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores CI
Feb. 08 Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Evolution of the average Target Price on Sonoma Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fe52c9137f842038eca16d7360ba8.HBnxaDNBXh3TgoerFdc0wJM4Kbgtsnv4VQ1tuwyIxsQ.TS-4BQYTEk-Y19XmRJwBn8ZXBIxL1iyAG18EzEb_kIglSZ9edGwtL-e17A~776e72e3c009fb0649effd62932fabd8

Analyst Recommendations on Sonoma Pharmaceuticals, Inc.

Ladenburg Thalmann Initiates Coverage on Sonoma Pharmaceuticals at Buy, $3.25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2047
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sonoma Pharmaceuticals, Inc.

Ladenburg Thalmann

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Consensus Sonoma Pharmaceuticals, Inc.